Synageva Biopharma Corporation

Lexington, MA 02421

SBIR Award Summary

Total Number of Awards 12
Total Value of Awards $3.2MM
First Award Date 05/01/03
Most Recent Award Date 05/01/11

Key Personnel

Last Name Name Awards Contact
Parker Stephen H Parker 1
Leavitt Mark C. Leavitt 5
Harvey Alex Jordan Harvey 4
Christmann Leandro Christmann 2

12 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 05/01/11 - 04/30/12

DESCRIPTION (provided by applicant): The impact of protein-based pharmaceuticals in the treatment of disease continues to surge, driven by discoveries in genomics and successful implementation by the biotechnology industry. The production of proteins remains a challenge because of the increasing demand and need for large doses. Many proteins req...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 05/15/10 - 04/30/11

DESCRIPTION (provided by applicant): The impact of protein-based pharmaceuticals in the treatment of disease continues to surge, driven by discoveries in genomics and successful implementation by the biotechnology industry. The production of proteins remains a challenge because of the increasing demand and need for large doses. Many proteins req...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-13
Budget: 07/15/08 - 10/14/09

DESCRIPTION (provided by applicant): The impact of protein-based pharmaceuticals in the treatment of disease continues to surge, driven by discoveries in genomics and successful implementation by the biotechnology industry. The production of proteins remains a challenge because of the increasing demand and need for large doses. Many proteins re...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/07 - 01/31/08

DESCRIPTION (provided by applicant): This phase II SBIR project will test the feasibility of producing large amounts of human monoclonal antibody into transchromosomic avian egg white. We will use a full length ovomucoid genomic locus expression construct created and tested in phase I, to drive expression of the monoclonal's heavy and light cha...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/22/06 - 04/21/08

DESCRIPTION (provided by applicant): This Phase II SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Chickens are able to produce large amounts of protein in their eggs at relatively low cost. We seek to harness this capability to synthesize pharmaceutical proteins, su...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/06 - 01/31/07

DESCRIPTION (provided by applicant): This phase II SBIR project will test the feasibility of producing large amounts of human monoclonal antibody into transchromosomic avian egg white. We will use a full length ovomucoid genomic locus expression construct created and tested in phase I, to drive expression of the monoclonal's heavy and light cha...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/05 - 07/31/06

DESCRIPTION (provided by applicant): With a daily production of 400 to 2500 milligrams of protein per egg, the chicken ovomucoid and ovalbumin gene loci have the potential to synthesize large amounts of biopharmaceutical proteins in transgenic hens. This phase II SBIR project will test the feasibility of using large oviduct protein genomic locus...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/22/05 - 04/21/06

DESCRIPTION (provided by applicant): This Phase II SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Chickens are able to produce large amounts of protein in their eggs at relatively low cost. We seek to harness this capability to synthesize pharmaceutical proteins, su...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/04 - 07/31/05

DESCRIPTION (provided by applicant): With a daily production of 400 to 2500 milligrams of protein per egg, the chicken ovomucoid and ovalbumin gene loci have the potential to synthesize large amounts of biopharmaceutical proteins in transgenic hens. This phase II SBIR project will test the feasibility of using large oviduct protein genomic locus...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/04 - 03/31/05

DESCRIPTION (provided by applicant): This project is focused on the development of a novel transgenic avian production platform that will provide human therapeutics in a rapid, cost-effective fashion. Specifically, we intend to create transgenic Japanese quail (Coturnix Coturnix sp. japonica) that produce humanized monoclonal antibody (huMAb) w...

Load More